Novo Nordisk Lifts 2026 Guidance as Wegovy Pill Beats Forecasts, but Analysts Split on the Road Ahea - ad-hoc-news.de Novo Nordisk Lifts 2026 Guidance as Wegovy Pill Beats Forecasts, but Analysts Split on the Road Ahea ad-hoc-news.de
Meantly / Novo Nordisk
Rhetoric profile
Novo Nordisk
Across 112 statements tracked since 24 Oct 2026, Novo Nordisk's most frequent rhetorical moves are leverage and threat & fear.
Meantly read
Most used moves, last 90 days
Audience impact, last 30 days
+1 leans reassuring
This week against their usual
Hostility this week 0.1 / 10, 0.8 below their usual 0.9.
Latest statements
Novo Nordisk stock gains 0.87% as Wegovy pill lifts outlook - ad-hoc-news.de Novo Nordisk stock gains 0.87% as Wegovy pill lifts outlook ad-hoc-news.de
Novo Nordisk Lifts Guidance as Wegovy Pill Outpaces Injections — and Analysts Can't Agree on What - ad-hoc-news.de Novo Nordisk Lifts Guidance as Wegovy Pill Outpaces Injections — and Analysts Can't Agree on What ad-hoc-news.de
Novo Nordisk announces new real-world data from PLATINUM-Truveta, RHODIUM-2 - TipRanks Novo Nordisk announces new real-world data from PLATINUM-Truveta, RHODIUM-2 TipRanks
Novo Nordisk A/S : Bernstein keeps a Sell rating - www.marketscreener.com Novo Nordisk A/S : Bernstein keeps a Sell rating www.marketscreener.com
Bernstein raises price target for Novo Nordisk to 223 Danish kroner (203), reiterates underperform - BN - marketscreener.com Bernstein raises price target for Novo Nordisk to 223 Danish kroner (203), reiterates underperform - BN marketscreener.com
SB1 Markets raises its price target for Novo Nordisk to DKK 345 (335), reiterates buy - marketscreener.com SB1 Markets raises its price target for Novo Nordisk to DKK 345 (335), reiterates buy marketscreener.com
Novo Nordisk Bounces Back: Wegovy Pill Sales Surge as 2026 Outlook Gets Major Boost - Medical Dialogues Novo Nordisk Bounces Back: Wegovy Pill Sales Surge as 2026 Outlook Gets Major Boost Medical Dialogues
Novo Nordisk raises forecast as pill sales beat Q3 2026 estimates - Quartz Novo Nordisk raises forecast as pill sales beat Q3 2026 estimates Quartz
BMO raises Novo Nordisk stock price target on Wegovy strength - Investing.com BMO raises Novo Nordisk stock price target on Wegovy strength Investing.com
BMO raises Novo Nordisk stock price target on Wegovy strength By Investing.com - Investing.com India BMO raises Novo Nordisk stock price target on Wegovy strength By Investing.com Investing.com India
BMO raises Novo Nordisk stock price target on Wegovy strength By Investing.com - Investing.com Canada BMO raises Novo Nordisk stock price target on Wegovy strength By Investing.com Investing.com Canada
Quotes are attributed automatically from official transcripts and news reports and can occasionally be wrong. Every item links to its source. Report an error.